Amphastar Pharmaceuticals, Inc. (AMPH) › Shareholders' EquityAmphastar Pharmaceuticals, Inc. (AMPH) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2015: $293.49M2016: $326.52M2017: $333.74M2018: $364.36M2019: $427.53M2020: $448.72M2021: $445.52M2022: $528.66M2023: $639.42M2024: $732.30M2025: $788.80M$788.80M2015Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$788.80M+7.7%2024$732.30M+14.5%2023$639.42M+21.0%2022$528.66M+18.7%2021$445.52M-0.7%2020$448.72M+5.0%2019$427.53M+17.3%2018$364.36M+9.2%2017$333.74M+2.2%2016$326.52M+11.3%2015$293.49M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share